iShares Canadian Fundamental Index ETF (ticker: CRQ on Cboe Canada; CFYFF US OTC) is an exchange-traded fund managed by BlackRock Asset Management Canada Ltd. that seeks to replicate the performance of the FTSE RAFI Canada Index, net of expenses. The fund invests in equity securities of the largest Canadian public issuers, selected and weighted based on fundamental factors including dividends, free cash flow, sales, and book value; it holds approximately 103 stocks across diversified sectors with a focus on large-cap Canadian companies. It offers quarterly distributions, a management fee of 0.65%, and a management expense ratio of 0.72%, with net assets of around CAD 102.56 million as of recent data.
The ETF provides investors exposure to Canadian equities through a fundamentally weighted methodology that aims to avoid market-capitalization biases inherent in traditional indexing. Key portfolio characteristics include a price-to-book ratio of 1.85, price-to-earnings ratio of 19.05, and a 12-month trailing yield of 2.47%. It trades on Cboe Canada, is eligible for registered plans such as RRSPs, and supports programs like PACC/DRIP/SWP.
Launched on February 22, 2006, and headquartered in Toronto through its manager BlackRock Asset Management Canada Ltd., a subsidiary of BlackRock, Inc., the fund primarily serves Canadian and international investors targeting fundamental indexing strategies in the Canadian equity market. Geographically, it focuses operations on Canadian-listed securities while being accessible via US OTC markets under CFYFF.
In recent years, the fund participated in BlackRock Canada's 2018 reclassification of advisor class units (CRQ.A) into common units to simplify the product lineup and align with industry trends toward transparent fee structures, completing the transition by April 2018. More recently, as of 2025, BlackRock Canada announced estimated annual reinvested capital gains distributions and regular cash distributions for the iShares ETFs, including this fund, reflecting ongoing portfolio management and investor payouts amid strong performance. No major acquisitions, new product launches specific to this ETF, or strategic shifts have been reported in the last 1-2 years, with focus remaining on index replication and routine distributions.